NCT00273481已完成4 期
Cosopt Versus Xalacom
Pharmaceutical Research Network4 个研究点 分布在 2 个国家目标入组 33 人开始时间: 2005年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
- 试验地点
- 4
研究概览
简要总结
To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adults with primary open-angle or pigment-dispersion glaucoma, or ocular hypertension
- •at baseline the intraocular pressure should be 20 to 32 mm Hg inclusive at 08:00 measurement (Visit 2) after dosing with timolol the evening before
- •the intraocular pressure should be 32 mm Hg or less at all the time points in both eyes at Visit 2
- •visual acuity should be 6/60 or better in the study eye(s)
排除标准
- •any anticipated change in systemic hypotensive therapy during the trial
- •use of any corticosteroids by any route for more than two weeks during the study
- •contraindications to study medicines
研究者
研究点 (4)
Loading locations...
相似试验
已完成
4 期
Lumigan Versus CosoptOpen-Angle GlaucomaNCT00273455Pharmaceutical Research Network34
已完成
4 期
24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed CombinationsOpen-angle GlaucomaNCT00397241Aristotle University Of Thessaloniki33
已完成
4 期
Latanoprost Versus FotilOpen-Angle GlaucomaOcular HypertensionNCT00304785Pharmaceutical Research Network36
已完成
不适用
Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective DataGlaucomaNCT01145898Indiana University56
已完成
4 期
Cosopt Versus XalatanOpen-Angle GlaucomaOcular HypertensionNCT00273429Pharmaceutical Research Network